![Federico Gardini](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Federico Gardini
Corporate Officer/Principal presso Bio3 Research SRL
Posizioni attive di Federico Gardini
Società | Posizione | Inizio | Fine |
---|---|---|---|
Bio3 Research SRL
![]() Bio3 Research SRL Medical SpecialtiesHealth Technology Bio3 Research SRL is engaged in the research, identification and development of novel therapeutic agents, specializing in the biotechnology, bioelectronics, and biomedicine fields. The firm develops proprietary compounds that serve as inhibitors in diseases related to High Mobility Group Box 1 (HMGB1) protein over-expression and biological properties. It monitors the effect of developed and patented biological agents on cardiovascular disorders, renal disorders, and connective tissue regeneration, such as cartilage repair, wound healing, and bone matrix regeneration. It collaborates with biopharmaceutical companies, academies, and scientists, with focus on intellectual property transfer, patent registration, and commercialization of novel products in the pharmaceutical marketplace. The company was founded by Francesco Paolo Pilato in 2001 and is headquartered in Milan, Italy. | Corporate Officer/Principal | - | - |
Storia della carriera di Federico Gardini
Precedenti posizioni note di Federico Gardini
Società | Posizione | Inizio | Fine |
---|---|---|---|
Bio3 Research, Inc. | Direttore operativo | - | - |
Formazione di Federico Gardini
University of Bocconi | Undergraduate Degree |
Statistiche
Distribuzione geografica
Italia | 3 |
Stati Uniti | 2 |
Posizioni
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Chief Operating Officer | 1 |
Settori
Consumer Services | 2 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Bio3 Research SRL
![]() Bio3 Research SRL Medical SpecialtiesHealth Technology Bio3 Research SRL is engaged in the research, identification and development of novel therapeutic agents, specializing in the biotechnology, bioelectronics, and biomedicine fields. The firm develops proprietary compounds that serve as inhibitors in diseases related to High Mobility Group Box 1 (HMGB1) protein over-expression and biological properties. It monitors the effect of developed and patented biological agents on cardiovascular disorders, renal disorders, and connective tissue regeneration, such as cartilage repair, wound healing, and bone matrix regeneration. It collaborates with biopharmaceutical companies, academies, and scientists, with focus on intellectual property transfer, patent registration, and commercialization of novel products in the pharmaceutical marketplace. The company was founded by Francesco Paolo Pilato in 2001 and is headquartered in Milan, Italy. | Health Technology |
Bio3 Research, Inc. |
- Borsa valori
- Insiders
- Federico Gardini
- Esperienza